Search
Sunshine Biopharma Inc
SBFMAdd to Watchlist
1.150USD
-0.080-6.50%
Close 07-31 16:00（ET）Quotes delayed by 15 min
564.18KMarket Cap
LossP/E TTM
More Details of Sunshine Biopharma Inc Company
Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Sunshine Biopharma Inc Info
Ticker SymbolSBFM
Company nameSunshine Biopharma Inc
IPO dateAug 15, 2008
CEOSlilaty (Steve N)
Number of employees52
Security typeOrdinary Share
Fiscal year-endAug 15
Address333 Las Olas Way
CityFORT LAUDERDALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33301
Phone19543300684
Websitehttps://www.sunshinebiopharma.com/
Ticker SymbolSBFM
IPO dateAug 15, 2008
CEOSlilaty (Steve N)
Company Executives of Sunshine Biopharma Inc
Name
Name/Position
Position
Shareholding
Change
Mr. David Natan
Mr. David Natan
Independent Director
Independent Director
10.00K
--
Dr. Abderrazzak Merzouki
Dr. Abderrazzak Merzouki
Chief Operating Officer, Director
Chief Operating Officer, Director
59.00
--
Dr. Steve N. Slilaty
Dr. Steve N. Slilaty
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
6.00
--
Mr. Camille Sebaaly
Mr. Camille Sebaaly
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
6.00
--
Mr. Michel Roy
Mr. Michel Roy
Chief Commercial Officer
Chief Commercial Officer
1.00
--
Dr. Rabi Kiderchah, M.D.
Dr. Rabi Kiderchah, M.D.
Independent Director
Independent Director
--
--
Dr. Andrew M. Keller
Dr. Andrew M. Keller
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David Natan
Mr. David Natan
Independent Director
Independent Director
10.00K
--
Dr. Abderrazzak Merzouki
Dr. Abderrazzak Merzouki
Chief Operating Officer, Director
Chief Operating Officer, Director
59.00
--
Dr. Steve N. Slilaty
Dr. Steve N. Slilaty
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
6.00
--
Mr. Camille Sebaaly
Mr. Camille Sebaaly
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
6.00
--
Mr. Michel Roy
Mr. Michel Roy
Chief Commercial Officer
Chief Commercial Officer
1.00
--
Dr. Rabi Kiderchah, M.D.
Dr. Rabi Kiderchah, M.D.
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Sunshine Biopharma Inc?
The top five shareholders of Sunshine Biopharma Inc are: Mr. David Natan
How many institutions hold shares of Sunshine Biopharma Inc (SBFM)?
As of 2026Q1, 35 institutions hold shares of Sunshine Biopharma Inc, with a combined market value of approximately 253.46K, accounting for 5.17% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -345977.00.